Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Chubb
Cipla
Argus Health
Julphar
Boehringer Ingelheim
Cerilliant
QuintilesIMS
AstraZeneca
Healthtrust

Generated: December 12, 2017

DrugPatentWatch Database Preview

XYLOCAINE Drug Profile

« Back to Dashboard

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi UsaXYLOCAINE W/ EPINEPHRINEepinephrine; lidocaine hydrochlorideINJECTABLE;INJECTION006488-019Nov 13, 1986APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
AstrazenecaXYLOCAINE W/ EPINEPHRINEepinephrine; lidocaine hydrochlorideINJECTABLE;INJECTION010418-008Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi UsaXYLOCAINE W/ EPINEPHRINEepinephrine; lidocaine hydrochlorideINJECTABLE;INJECTION006488-004Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi UsaXYLOCAINE W/ EPINEPHRINEepinephrine; lidocaine hydrochlorideINJECTABLE;INJECTION006488-012Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
AstrazenecaXYLOCAINElidocaineAEROSOL;ORAL014394-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Dentsply PharmXYLOCAINE DENTAL WITH EPINEPHRINEepinephrine; lidocaine hydrochlorideINJECTABLE;INJECTION021381-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi UsaXYLOCAINE PRESERVATIVE FREElidocaine hydrochlorideINJECTABLE;INJECTION016801-004Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi UsaXYLOCAINElidocaine hydrochlorideINJECTABLE;INJECTION006488-010Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
AstrazenecaXYLOCAINElidocaine hydrochlorideINJECTABLE;INJECTION010418-007Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
AstrazenecaXYLOCAINElidocaineSUPPOSITORY;RECTAL013077-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Citi
Johnson and Johnson
Daiichi Sankyo
UBS
Novartis
Federal Trade Commission
Fuji
Cipla
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot